PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 18 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $354,000 | +2.6% | 400,000 | 0.0% | 0.09% | +17.8% |
| Q2 2022 | $345,000 | -2.5% | 400,000 | 0.0% | 0.07% | +19.7% |
| Q1 2022 | $354,000 | -3.3% | 400,000 | 0.0% | 0.06% | +17.3% |
| Q4 2021 | $366,000 | +3.7% | 400,000 | 0.0% | 0.05% | +2.0% |
| Q3 2021 | $353,000 | -1.1% | 400,000 | 0.0% | 0.05% | +6.2% |
| Q2 2021 | $357,000 | -0.3% | 400,000 | 0.0% | 0.05% | -5.9% |
| Q1 2021 | $358,000 | +3.2% | 400,000 | 0.0% | 0.05% | +4.1% |
| Q4 2020 | $347,000 | +5.5% | 400,000 | 0.0% | 0.05% | -14.0% |
| Q3 2020 | $329,000 | +1.9% | 400,000 | 0.0% | 0.06% | +9.6% |
| Q2 2020 | $323,000 | +22.8% | 400,000 | 0.0% | 0.05% | +20.9% |
| Q1 2020 | $263,000 | -8.0% | 400,000 | 0.0% | 0.04% | +48.3% |
| Q4 2019 | $286,000 | +2.1% | 400,000 | 0.0% | 0.03% | +3.6% |
| Q3 2019 | $280,000 | +2.6% | 400,000 | 0.0% | 0.03% | +7.7% |
| Q2 2019 | $273,000 | – | 400,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PenderFund Capital Management Ltd. | 20,060,000 | $23,311,000 | 5.66% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 44,492,000 | $39,153,000 | 1.56% |
| UBS OCONNOR LLC | 26,000,000 | $23,448,000,000 | 0.34% |
| Saltoro Capital, LP | 750,000 | $678,000 | 0.17% |
| AQR Arbitrage LLC | 3,050,000 | $2,758,000 | 0.10% |
| WATER ISLAND CAPITAL LLC | 1,500,000 | $1,371,000 | 0.08% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,448,000 | $3,103,000 | 0.07% |
| OAKTREE CAPITAL MANAGEMENT LP | 5,780,000 | $5,227,000 | 0.07% |
| Teton Advisors, Inc. | 400,000 | $358,000 | 0.05% |
| MACQUARIE GROUP LTD | 8,175,000 | $7,393,000 | 0.01% |